Clinical Trial Update: GSK1349572 Relative Bioavailability Study [Phase 1]

View source ↗

Summary

Phase 1 relative bioavailability study of GSK1349572 (dolutegravir) completed to characterize pharmacokinetics and bioavailability.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• Tivicay (dolutegravir)

Snippet

Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus | Phase 1 | Status: COMPLETED